跳至主要内容
临床试验/NCT02590549
NCT02590549已完成不适用

Complete Corneal Ring (MyoRing) Implantation Combined With Corneal Collagen Crosslinking for Keratoconus

Ufa Eye Research Institute0 个研究点目标入组 16 人开始时间: 2011年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
16
主要终点
K max

研究概览

简要总结

A complete intrastromal ring, MyoRing (Dioptex, GmbH, Linz, Austria), suggested by Albert Daxer in 2007, is a relatively new technique that has been demonstrated to treat keratoconus safely and effectively.Corneal collagen crosslinking (CXL), introduced by Wollensak et al. in 2003, has become a standard treatment for progressive keratoconus to slow or possibly stop progression of disease.

The formation of the stromal pocket during MyoRing implantation offers the opportunity for simultaneous introduction of riboflavin 0.1% into the pocket followed by UVA irradiation to provide combined treatment in patients with progressive keratoconus.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >18 years old
  • a diagnosis of keratoconus, intolerance for contact lenses or glasses
  • a documented progression of disease. This progression was defined by the following changes over 1 year: an increase of the steepest K by 1.0 diopter (D) or more in manifest cylinder, or an increase of 0.5 D or more in manifest spherical equivalent (SE) refraction by repeated keratotopography ODP-scan ARK-1000 (Nidek, Japan)

排除标准

  • minimal pachymetry of less than 380 μm,
  • a history of previous ocular pathology or ocular surgery;
  • pregnancy or breastfeeding;
  • corneal scarring.

结局指标

主要结局

K max

时间窗: 2 years

Using topography measurements, decrease of maximum keratometry value over the preoperative maximum keratometry value

次要结局

  • Visual acuity as assessed by Decimal system(2 years)

研究者

发起方
Ufa Eye Research Institute
申办方类型
Other
责任方
Sponsor

相似试验